Praxis Precision Medicines (PRAX) Current Leases (2019 - 2026)

Praxis Precision Medicines' Current Leases history runs 8 years deep, the most recent figure standing at $1.4 million for Q1 2026.

• In Q1 2026, Current Leases rose 34.62% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $1.4 million (up 34.62% YoY), while the FY2025 annual figure was $110000.0, down 91.26% from the prior year.
• Current Leases was $1.4 million for Q1 2026 at Praxis Precision Medicines, up from $110000.0 in the prior quarter.
• In the past five years, Current Leases ranged from a high of $1.4 million in Q1 2026 to a low of $110000.0 in Q4 2025.
• Historically, Current Leases has averaged $994705.9 across 5 years, with a median of $1.1 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Current Leases jumped 77.34% in 2022, then slumped 91.26% in 2025.
• A 5-year view of Current Leases shows it stood at $1.0 million in 2022, then climbed by 12.04% to $1.1 million in 2023, then increased by 11.81% to $1.3 million in 2024, then plunged by 91.26% to $110000.0 in 2025, then soared by 1204.55% to $1.4 million in 2026.
• The last three Current Leases figures came in at $1.4 million (Q1 2026), $110000.0 (Q4 2025), and $436000.0 (Q3 2025), per Business Quant data.